A phase II open label trial evaluating safety andefficacy of a telomerase peptide vaccination inpatients with advanced hepatocellular carcinoma. - Greten, Tim F.; Forner, Alejandro; Korangy, Firouzeh; N'Kontchou, Gisele; Barget, Nathalie; Ayuso, Carmen; Ormandy, Lars A.; Manns, Michael P.; Beaugrand, Michel; Bruix, Jordi (BMC Cancer, 2010)